Group One Trading
LXEO icon

Group One Trading’s Lexeo Therapeutics LXEO Stock Holding History

Group One Trading’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,000
Closed -$19.9K – 8260
2025
Q4 		$19.9K Sell
2,000
-900
-31% -$8.21K ﹤0.01% 6342
2025
Q3 		$19.3K Buy
+2,900
New +$14K ﹤0.01% 6718

Other funds holding LXEO

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's LXEO Position: Q1 2026 in Review

Group One Trading reduced its Lexeo Therapeutics (LXEO) stake by 28% in Q1 2026, selling an estimated $3.6K and leaving 1,308 shares worth $7.51K. The position accounts for ﹤0.01% of the portfolio, ranked #6526.

Group One Trading first reported a position in LXEO in Q4 2025 and has held it in 2 quarters since. The position peaked at $18K in Q4 2025. 139 funds tracked by Wall St. Rank hold LXEO as of Q1 2026.

  • Group One Trading held 1,308 shares of Lexeo Therapeutics worth $7.51K as of Q1 2026.
  • Group One Trading sold 508 Lexeo Therapeutics shares in Q1 2026, an estimated $3.6K.
  • Lexeo Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6526 holding.
  • Group One Trading first reported a position in Lexeo Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Group One Trading's Lexeo Therapeutics position peaked at $18K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.